C
Carmen Burtea
Researcher at University of Mons
Publications - 74
Citations - 1797
Carmen Burtea is an academic researcher from University of Mons. The author has contributed to research in topics: Phage display & Peptide. The author has an hindex of 22, co-authored 71 publications receiving 1665 citations. Previous affiliations of Carmen Burtea include Université libre de Bruxelles & Guerbet.
Papers
More filters
Journal ArticleDOI
Crucial Ignored Parameters on Nanotoxicology: The Importance of Toxicity Assay Modifications and “Cell Vision”
Sophie Laurent,Carmen Burtea,Coralie Thirifays,Urs O. Häfeli,Morteza Mahmoudi,Morteza Mahmoudi +5 more
TL;DR: The modification of conventional toxicity assays and the consideration of the “cell vision” concept are crucial matters to obtain reliable, and reproducible nanotoxicology data and offer a suitable way to obtain a deep understanding on the cell-NP interactions.
Journal ArticleDOI
Cell “vision”: complementary factor of protein corona in nanotoxicology
Morteza Mahmoudi,Morteza Mahmoudi,Seyyed Nasirodin Saeedi-Eslami,Mohammad Ali Shokrgozar,Kayhan Azadmanesh,Maryam Hassanlou,Hamid Reza Kalhor,Carmen Burtea,Barbara Rothen-Rutishauser,Sophie Laurent,Sara Sheibani,Hojatollah Vali +11 more
TL;DR: In addition to protein adsorption, the concept of cell "vision" is introduced, which would be recognized as another crucial factor that should be considered for the safe design of any type of nanoparticles that will be used in specific biomedical applications.
Book ChapterDOI
Contrast agents: magnetic resonance.
TL;DR: A new generation of MRI CAs is progressively emerging in the current context of molecular imaging, agents that are designed to detect with a high specificity the cellular and molecular hallmarks of various pathologies.
Journal ArticleDOI
Molecular imaging of αvβ3 integrin expression in atherosclerotic plaques with a mimetic of RGD peptide grafted to Gd-DTPA
Carmen Burtea,Sophie Laurent,Oltea Murariu,Dirk Rattat,Gérard Toubeau,A. Verbruggen,David Vansthertem,Luce Vander Elst,Robert N. Muller +8 more
TL;DR: The delayed blood clearance, the significant enhancement of the signal-to-noise ratio, and the low immunogenicity of the mimetic molecule highlight its potential for an industrial and clinical implementation.
Journal ArticleDOI
Peptidic targeting of phosphatidylserine for the MRI detection of apoptosis in atherosclerotic plaques
Carmen Burtea,Sophie Laurent,Eric Lancelot,Sébastien Ballet,Oltea Murariu,Olivier Rousseaux,Marc Port,Luce Vander Elst,Claire Corot,Robert N. Muller +9 more
TL;DR: The in vivo MRI studies performed at 4.7 T provide proof of concept that apoptosis-related pathologies could be diagnosed by MRI with a low molecular weight paramagnetic agent.